950 Shares in Veeva Systems Inc. (NYSE:VEEV) Purchased by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC bought a new position in shares of Veeva Systems Inc. (NYSE:VEEV) during the fourth quarter, HoldingsChannel reports. The institutional investor bought 950 shares of the technology company’s stock, valued at approximately $222,000.

Other hedge funds have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its position in shares of Veeva Systems by 72.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock valued at $25,000 after purchasing an additional 50 shares during the period. Centricity Wealth Management LLC acquired a new position in shares of Veeva Systems in the 4th quarter valued at $25,000. True Wealth Design LLC boosted its position in shares of Veeva Systems by 3,375.0% in the 3rd quarter. True Wealth Design LLC now owns 139 shares of the technology company’s stock valued at $29,000 after purchasing an additional 135 shares during the period. Retirement Wealth Solutions LLC acquired a new position in shares of Veeva Systems in the 4th quarter valued at $31,000. Finally, Avion Wealth boosted its position in shares of Veeva Systems by 635.0% in the 4th quarter. Avion Wealth now owns 147 shares of the technology company’s stock valued at $30,000 after purchasing an additional 127 shares during the period. 88.20% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently weighed in on VEEV shares. Piper Sandler increased their price target on Veeva Systems from $280.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Truist Financial decreased their price objective on Veeva Systems from $261.00 to $210.00 and set a “hold” rating for the company in a research report on Monday, January 13th. Stifel Nicolaus raised their price objective on Veeva Systems from $240.00 to $272.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Barclays raised their price objective on Veeva Systems from $260.00 to $275.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Finally, Scotiabank raised their price objective on Veeva Systems from $235.00 to $240.00 and gave the stock a “sector perform” rating in a research report on Friday, December 6th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $254.48.

Veeva Systems Trading Up 0.9 %

NYSE VEEV opened at $220.32 on Thursday. The stock has a 50-day simple moving average of $223.82 and a 200 day simple moving average of $219.54. The company has a market capitalization of $35.77 billion, a PE ratio of 54.40, a P/E/G ratio of 1.89 and a beta of 0.85. Veeva Systems Inc. has a 12 month low of $170.25 and a 12 month high of $258.93.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.